Company intelligence / Profile preview

Weigao Group

Weihai, Shandong, Chinaen.weigaogroup.com ↗
Ownership
Private
Employees
~30000
Development stage
Other
01

Overview

Weigao Group has a broad commercial portfolio of over 1,000 types of medical devices and pharmaceuticals across more than 200 therapeutic areas. Recent regulatory milestones include FDA clearances for vitrification kits and catheters via subsidiaries. The company’s products are widely used in hospitals and clinics globally.

Therapeutic areas
NeurologyInfectious DiseasesOtherNephrologyRheumatology
Modalities
DeviceBiologicSmall moleculeRecombinant proteinPolymer-based medical device
Industry
Biotech
02

Partnerships

Recent collaborations with the Shandong Medical Association noted.

Beyond the preview

Go deeper on Weigao Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Weigao Group.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call